For labs looking to uncover weak protein interactions, conventional methods aren’t ideal. Consider exclusion-based sample preparation from EXTRACTMAN instead.
Josh Martin, a graduate research assistant and Ph.D. candidate with the McCardle Laboratory for Cancer Research, discusses how EXTRACTMAN helps to overcome limitations of the immunoprecipitation techniques that aim to identify and isolate binding partners of proteins.
Protein-protein interactions play an ever important role in oncogenesis. In this video, Dr. Richard Burgess, Professor Emeritus of Oncology at the University of Wisconsin, discusses approaches to characterize weak protein interactions that are targeted by cancer researchers.
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology has been used to create useful animal models for studying complex diseases, as well as correcting or inducing disease states within a cell. This technical note describes how PLATEMASTER and EXTRACTMAN can be used in the rapid enrichment and clonal selection of CRISPR modified cells.
This application note presents a new approach for the cleanup of DNA fragments from small volumes of liquid combining the innovative design of EXTRACTMAN® with the convenience of a DNA purification using MACHEREY-NAGEL’s proven NucleoMag® technology.
RNA-binding proteins (RBPs) are involved in many key cellular processes, but identification of the native binding partners (target RNAs) can be challenging. In this application note, we show that EXTRACTMAN can be used to efficiently and specifically enrich endogenously expressed ribonucleoprotein complexes.
EXTRACTMAN® improved isolation speed nine-fold and produced equivalent or better yields of purified DNA compared to tube-based isolation methods. In this application note, four DNA samples from two different organisms (mammalian and plant) were processed in parallel with no cross-contamination.
In this app note, superparamagnetic Protein G particles from three suppliers were tested with a simple immunoprecipitation protocol to evaluate their performance on EXTRACTMAN.
This application note describes a comparison of a conventional Co-IP protocol with an EXTRACTMAN® protocol using ESP technology. While the conventional Co-IP protocol did not pull down the protein-protein complex, EXTRACTMAN did, demonstrating the utility of ESP technology and EXTRACTMAN.